Catalyst Wire Dossier Catalyst Wire Dossier

Cenerimod

cenerimod · Viatris Innovation GmbH
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Cenerimod, covering 2023-09-22 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE) [Phase 2]

See pricing